MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 77 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,638 | -53.9% | 35,483 | -37.8% | 0.00% | -100.0% |
| Q2 2023 | $619,302 | +281.2% | 57,026 | +142.2% | 0.00% | – |
| Q1 2023 | $162,447 | +38.8% | 23,543 | +33.2% | 0.00% | – |
| Q3 2022 | $117,000 | -54.3% | 17,669 | -35.5% | 0.00% | -100.0% |
| Q1 2022 | $256,000 | +8.0% | 27,387 | +37.6% | 0.00% | 0.0% |
| Q4 2021 | $237,000 | -62.6% | 19,900 | -64.2% | 0.00% | -50.0% |
| Q3 2021 | $633,000 | – | 55,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 3,629,622 | $41,305,000 | 7.74% |
| VR Adviser, LLC | 2,641,809 | $30,064,000 | 3.86% |
| Bleichroeder LP | 1,062,500 | $12,091,000 | 1.96% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $16,285,000 | 1.01% |
| Boxer Capital, LLC | 2,400,000 | $27,312,000 | 0.95% |
| 683 Capital Management, LLC | 1,929,929 | $21,963,000 | 0.86% |
| Avoro Capital Advisors LLC | 3,235,000 | $36,814,000 | 0.58% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,197,426 | $25,007,000 | 0.42% |
| Granite Point Capital Management, L.P. | 419,324 | $4,772,000 | 0.36% |
| KNOTT DAVID M | 81,166 | $924,000 | 0.34% |